Sigmart



Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 18.3%
Myocardial Infarction 14.1%
Drug Use For Unknown Indication 12.9%
Angina Pectoris 10.2%
Percutaneous Coronary Intervention 5.5%
Product Used For Unknown Indication 5.5%
Prophylaxis 4.5%
Cardiac Failure 3.8%
Diabetes Mellitus 3.2%
Cardiac Failure Chronic 2.7%
Gastritis Prophylaxis 2.7%
Gastric Ulcer Haemorrhage 2.6%
Hyperlipidaemia 2.5%
Acute Coronary Syndrome 2.0%
Polyuria 1.8%
Gastritis 1.7%
Infection 1.6%
Insomnia 1.6%
Hypercholesterolaemia 1.5%
Acute Myocardial Infarction 1.4%
Liver Disorder 14.8%
Liver Function Test Abnormal 9.3%
Toxic Skin Eruption 7.4%
Interstitial Lung Disease 6.5%
Ventricular Extrasystoles 6.5%
Condition Aggravated 5.6%
Pyrexia 5.6%
Asthma 4.6%
Renal Impairment 4.6%
Thrombocytopenic Purpura 4.6%
Jaundice Cholestatic 3.7%
Platelet Count Decreased 3.7%
White Blood Cell Count Decreased 3.7%
Acute Generalised Exanthematous Pustulosis 2.8%
Agranulocytosis 2.8%
Cardiac Failure 2.8%
Dermatitis Exfoliative 2.8%
Lymphocyte Stimulation Test Positive 2.8%
Monoplegia 2.8%
Pancytopenia 2.8%
Concomitant
Hypertension 17.0%
Angina Pectoris 14.5%
Product Used For Unknown Indication 9.1%
Prophylaxis 8.0%
Drug Use For Unknown Indication 7.3%
Cardiac Failure 5.8%
Diabetes Mellitus 4.2%
Myocardial Infarction 4.2%
Hyperlipidaemia 3.6%
Acute Coronary Syndrome 3.3%
Insomnia 2.8%
Angina Unstable 2.7%
Gastritis 2.6%
Cardiac Failure Chronic 2.6%
Constipation 2.5%
Acute Myocardial Infarction 2.4%
Rheumatoid Arthritis 2.1%
Type 2 Diabetes Mellitus 2.0%
Thrombosis Prophylaxis 1.8%
Asthma 1.8%
Interstitial Lung Disease 10.9%
Pneumonia 9.6%
Rhabdomyolysis 7.4%
Cardiac Failure 7.0%
Hepatic Function Abnormal 5.5%
Renal Impairment 5.1%
White Blood Cell Count Decreased 4.9%
White Blood Cell Count Increased 4.7%
Renal Failure Acute 4.5%
Death 4.1%
Liver Disorder 4.1%
Cerebral Infarction 3.9%
Myocardial Infarction 3.9%
Renal Failure 3.9%
Ventricular Tachycardia 3.7%
Vomiting 3.7%
Hypoglycaemia 3.5%
Pyrexia 3.3%
Small Intestine Ulcer 3.1%
Thrombosis In Device 3.1%